n(1)-methylnicotinamide has been researched along with Cirrhosis, Liver in 3 studies
N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Biliotti, E | 1 |
| Giampaoli, O | 1 |
| Sciubba, F | 1 |
| Marini, F | 1 |
| Tomassini, A | 1 |
| Palazzo, D | 1 |
| Capuani, G | 1 |
| Esvan, R | 1 |
| Spaziante, M | 1 |
| Taliani, G | 1 |
| Miccheli, A | 1 |
| Takeuchi, K | 1 |
| Yokouchi, C | 1 |
| Goto, H | 1 |
| Umehara, K | 1 |
| Yamada, H | 1 |
| Ishii, Y | 1 |
| Orlando, R | 1 |
| Floreani, M | 1 |
| Napoli, E | 1 |
| Padrini, R | 1 |
| Palatini, P | 1 |
3 other studies available for n(1)-methylnicotinamide and Cirrhosis, Liver
| Article | Year |
|---|---|
Urinary metabolomics of HCV patients with severe liver fibrosis before and during the sustained virologic response achieved by direct acting antiviral treatment.
Topics: Aged; Antiviral Agents; Biomarkers; Hepatitis C; Humans; Hydroxybutyrates; Liver Cirrhosis; Male; Me | 2021 |
Alleviation of fatty liver in a rat model by enhancing N
Topics: Aldehyde Oxidase; Animals; Biological Availability; Cytosol; Disease Models, Animal; Enzyme Inhibito | 2018 |
Renal clearance of N(1)-methylnicotinamide: a sensitive marker of the severity of liver dysfunction in cirrhosis.
Topics: Adult; Biological Transport, Active; Biomarkers; Case-Control Studies; Creatinine; Humans; Inulin; K | 2000 |